Imaging of pancreatic cancer using fluorine-18 fluorodeoxyglucose positron emission tomography

Journal of Gastrointestinal Surgery

Volumn 6, Issue 2, 2002, Pages 136-138

  Alazraki, Naomi ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOXORUBICIN; FLUORODEOXYGLUCOSE F 18; IODINE 131; PENTETREOTIDE IN 111; DIAGNOSTIC AGENT;

CANCER DIAGNOSIS; CANCER STAGING; CONFERENCE PAPER; DRUG HALF LIFE; DRUG UPTAKE; HUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CANCER; PANCREATITIS; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; SARCOMA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TREATMENT OUTCOME; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PANCREAS TUMOR; PATHOLOGY; REVIEW; SCINTISCANNING;

FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036518866     PISSN: 1091255X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1091-255X(01)00058-0     Document Type: Conference Paper

References (10)

1. Rose DM, Delbeke D, Beauchamp RD, et al. 18Fluorodeoxyglucose-positron emission tomography in the management of patients with suspected pancreatic cancer. Ann Surg 1999;229:729-737.
2. Delbeke D, Rose DM, Chapman WC, et al. Optimal interpretation of FDG PET in the diagnosis, staging and management of pancreatic carcinoma. J Nucl Med 1999;40: 1784-1791.
3. Franke C, Klapdor R, Meyerhoff K, et al. 18-FDG positron emission tomography of the pancreas: Diagnostic benefit in the follow-up of pancreatic carcinoma. Anticancer Res 1999; 19:2437-2442.
4. Kapucu LO, Meltzer CC, Townsend DW, et al. Fluorine-18-fluorodeoxyglucose uptake in pneumonia. J Nucl Med 1998;39:1267-1269.
5. Hoekstra OS, van Lingen A, Ossenkoppele GJ, et al. Early response monitoring in malignant lymphoma using fluorine-18 fluorodeoxyglucose single-photon emission tomography. Eur J Nucl Med 1993;20:1214-1217.
6. Eary JF, Krohn KA. Positron emission tomography: Imaging tumor response. Eur J Nucl Med 2000;27:1737-1739.
7. Maisey NR, Webb A, Flux GD, et al. FDG-PET in the prediction of survival of patients with cancer of the pancreas: a pilot study. Br J Cancer 2000;83:287-293.
8. Keogan MT, Tyler D, Clark L, et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. AJR 1998;171:1565-1570.
9. Diederichs CG, Staib L, Vogel, et al. Values and limitations of 18F-fluorodeoxyglucose-positron-emission tomography with preoperative evaluation of patients with pancreatic masses. Pancreas 2000;20:109-116.
10. Magnani P, Caretta A, Rizzo G, et al. FDG/PET and spiral CT image fusion for mediastinal lymph node assessment of non-small cell lung cancer patients. J Cardiovasc Surg (Torino) 1999;40:741-748.